Trials / Conditions / MASH - Metabolic Dysfunction-Associated Steatohepatitis

MASH - Metabolic Dysfunction-Associated Steatohepatitis

13 registered clinical trials studyying MASH - Metabolic Dysfunction-Associated Steatohepatitis — 12 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Betaine vs. Placebo for Serologically Diagnosed Metabolic Dysfunction-associated Steatohepatitis (MASH) NCT07276204	Southern California Institute for Research and Education	Phase 2
Not Yet Recruiting	Exercise for an Aging Liver (EXALIVER) NCT07467512	Consorcio Centro de Investigación Biomédica en Red (CIBER)	N/A
Recruiting	A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With NCT07491458	Rivus Pharmaceuticals, Inc.	Phase 2
Recruiting	Study of TGM-312-SC01 in Healthy Participants and Adults With MASH NCT07427680	Tangram Therapeutics Plc	Phase 1 / Phase 2
Not Yet Recruiting	A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes M NCT07303803	Shanghai Jiao Tong University School of Medicine	Phase 2
Active Not Recruiting	Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH NCT07335601	Madrigal Pharmaceuticals, Inc.	Phase 2
Recruiting	Resmiterom Efficacy & Safety in Patients With MASH NCT07249788	Nabiqasim Industries (Pvt) Ltd	Phase 4
Recruiting	To Test Whether Time-restricted Eating Coupled With a Healthy Diet is Beneficial in Liver Cancer Patients NCT06824974	University of California, San Diego	N/A
Recruiting	Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patient NCT06661655	E-Scopics	N/A
Recruiting	Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis NCT07013916	Queen Mary University of London	N/A
Recruiting	Digoxin In NASH (CODIN) NCT06588699	Yale University	Phase 2
Recruiting	High-Risk Transcriptome Molecular Prediction Study of MASH-Associated Colorectal Polyps NCT07463287	Shanghai East Hospital	—
Recruiting	A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH NCT06528314	Akero Therapeutics, Inc	Phase 3